Lerodalcibep-liga (Lerochol)
Customize your policy alerts
Sign up for QualChoice Policy CP.PHAR.768 alerts
Get alerted when Policy CP.PHAR.768 changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization and medical-necessity coverage for Lerochol, a PCSK9 inhibitor used with diet and exercise to reduce LDL-C in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia. It applies to QualChoice commercial, HIM/ICHRA, and Medicaid members.
The policy added the ICHRA line of business.
For all indications, the moderate- or low-intensity statin requirement was changed from prior use of one high-intensity statin with LDL remaining at least 70 mg/dL to failure to achieve the LDL goal applicable to the specific indication.
The recent LDL requirement for members with a history of ASCVD was changed to at least 55 mg/dL regardless of very-high-risk status.
Examples of increased cardiovascular-event risk were expanded to include diabetes, a 10-year estimated ASCVD risk of at least 10%, and a CAC score of 100 to 299 AU.
For heterozygous familial hypercholesterolemia, baseline LDL was simplified to at least 160 mg/dL for all ages and the recent LDL requirement was revised to at least 70 mg/dL.
For severe primary hypercholesterolemia with ASCVD risk factors, a recent LDL requirement of at least 70 mg/dL was added, while the at-least-100-mg/dL requirement was clarified as applying to patients without ASCVD risk factors.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.